youth aged 8-\<18 years with a diagnosis of migraine using gold standard International Classification of Headache Disorders criteria
self-reporting 2-14 headache days/month in the last 3 months
reporting prodromal symptoms that predict a headache within six hours \>75% of the time.
To proceed past the 60-day screening period to randomization, participants will need to report 3-28 qualifying prodrome events with \>75% of these events followed by a headache within 6 hours.
You may not be if
the inability to read or understand English
a diagnosis of psychosis, schizophrenia, or moderate-severe autism, moderate-severe developmental delay or moderate-severe intellectual disability
implanted electrical device
uncontrolled epilepsy (i.e., \>2 seizures in the past year)
abnormal skin on both upper arms
arm circumference \<20 cm
severe cardiac or cerebrovascular disease
prior participation in the trial
Clareo Health | Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth
